Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Pathology and Lab Medicine
15 active people
52 grants
Recent Grants
Anchor Biorepository, Sample Shipping and Handling, and Datafile Generation
2024
·
$311K
biorepository,
sample handling,
datafile generation,
sample shipping,
laboratory management
Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)
2023
·
$568.2K
colorectal cancer,
treatment,
clinical trial,
dkn-01,
chemotherapy
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers
2023
·
$509.8K
cancer,
chemotherapy,
clinical trial,
treatment,
combination therapy
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer
2023
·
$494.2K
cancer,
immunotherapy,
clinical trials,
metastasis,
treatment comparison
Actuate 1801. Phase 1/2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3B) Inhibitor, as a Single Agent and Combined with Chemotherapy, in Patients with Refractory Hematologic Malignancies
2023
·
$432.5K
gsk-3b inhibitor,
hematologic malignancies,
chemotherapy
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
2023
·
$253.9K
oncology,
clinical trial,
cancer treatment,
pharmacology,
molecular biology
University of Arizona Cancer Center - Cancer Center Support Grant
2022
·
$12.4M
cancer research,
medical oncology,
grants,
cancer treatment,
supportive care
Success, Health, Innovation, and Equity-Arizona Research Center (SHINE-ARC)
2022
·
$4.1M
health,
equity,
innovation,
research,
center
A Phase 2 Basket Trial of Ulixertinib (BVD-523) in Combination with Hydroxychloroquine in Patients with Advanced Gastrointestional Malignancies Harboring MAPK Pathway Mutations (BVD-523-HCQ)
2022
·
$497.7K
clinical trials,
oncology,
combination therapy,
mapk pathway mutations,
gastrointestinal malignancies
Quantitative MRI and Deep Learning Technologies for Classification of NAFLD
2022
·
$398.9K
quantitative mri,
deep learning,
nafld classification,
medical imaging,
machine learning
DNA methylation, Liquid Biopsy, and Pancreatic Cancer
2022
·
$391.1K
dna methylation,
liquid biopsy,
pancreatic cancer
AIDS and Cancer Specimen Resource (ACSR)- Impact of HIV-1 Infection on Epigenetic Regulations of Anti Tumor Immunity
2022
·
$286.5K
hiv-1 infection,
cancer specimen resource,
epigenetic regulations,
anti tumor immunity,
aids impact
A Phase IIb Study of ALX148 in Combination With Anti-pd-1 and Cetuximab in Patients With Refractory Microsatellite Stable Metastatic Colorectal Cancer
2022
·
$181.2K
immunotherapy,
colorectal cancer,
combination therapy,
metastatic cancer
Abdominal Adiposity in Early-Onset and Aggressive Clear Cell Renal Cell Carcinoma and Health Disparities
2021
·
$865.5K
cancer,
obesity,
health disparities,
renal cell carcinoma,
adiposity
ANCHOR- Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions (HSIL)
2020
·
$3.9M
anal cancer prevention,
hiv patients,
topical treatment,
ablative treatment,
high-grade squamous intraepithelial lesions
University of Arizona COVID-19 Serology Testing
2020
·
$3.5M
covid-19,
serology,
university,
testing,
arizona
University of Arizona COVID-19 Serology Testing
2020
·
$1M
covid-19,
serology,
university,
testing,
arizona
Advancing MRI Technology for Early Diagnosis of Liver Metastases
2019
·
$2.4M
mri technology,
liver metastases,
early diagnosis,
medical imaging,
cancer detection
A Randomized Phase II Study of Atezolizumab and A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC), HCRN GI19-405
2022
·
$112.9K
cancer,
immunotherapy,
clinical trial,
hepatocellular carcinoma,
treatment
Prospective Single Arm Medical Food Study to Evaluate a Standardized Nonessential Amino Acid Restriction (NEAAR) Medical Food for the Dietary Management of Metastatic Colorectal Cancer
2022
·
$99K
medical food,
amino acid restriction,
metastatic colorectal cancer,
dietary management
People
Achyut Bhattacharyya
Professor
Anil Rama Rao
Associate Professor
Alexis Elliott
Assistant Clinical Professor, Pathology - (Clinical Series Track)
Belinda Sun
Associate Professor, Pathology - (Clinical Scholar Track)
Catherine Perry
Professor
Deborah Fuchs
Professor, Pathology - (Educator Scholar Track)
Dennis McMillan
Research Technologist II
Hina Arif Tiwari
Professor
Lisa Rimsza
Department Chair
Mark Nelson
Professor
Maria Proytcheva
Professor, Pathology - (Clinical Scholar Track)
Demaretta Rush
Associate Professor, Pathology - (Clinical Scholar Track)
Monika Schmelz
Professor
